Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis.

NCT00217295 is registered in ClinicalTrials.gov with Multiple Sclerosis Institute as lead sponsor.

NCT NCT00217295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis.
Lead sponsor
Multiple Sclerosis Institute
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2004
Completion date
December 31, 2007
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis